NCT00098735View on ClinicalTrials.gov

Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2006

Conditions
Kidney Transplantation
Interventions
DRUG

FTY720

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY